% | $
Quotes you view appear here for quick access.

Opko Health, Inc. Message Board

  • defunct00 defunct00 Mar 26, 2009 6:27 PM Flag

    Back over a buck for now

    Can someone give me some insight other than insider buying why this thing is a hold......They still have no products near ready for the market right? Stuart creek you seem to know your stuff....?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • not for long...

    • To me, Dr. Frost's continued buying of OPK shares seems to be unrelated to the current intrinsic worth of this company.
      Someone smarter than me will have to ask him why he is buying these shares.
      If you look at eye care, Abbott just bough AMO, Bausch & Lomb was sold to private equity, Alcon is being bought by Novartis and now there are rumors that Allergan will be acquired.
      The demographics for eye care are terrific (baby boomers), but all of the above companies have many approved products and real revenue streams. I don't see these elements with OPK. Frost has thrown a lot of therapeutic concepts against the wall, I guess hoping that some of them work.
      That's the best I can do.

    • Sample of Dr Frost buying--------------------
      Insider buying hits 8-year low in '03
      Some CEOs rewarded for loading up in a rising market
      By Matt Andrejczak,
      Last update: 2:08 p.m. EST Jan. 8, 2004
      WASHINGTON (CBS.MW) -- Ivax Chairman and CEO Phillip Frost considers himself an impulsive buyer of his Miami-based company's shares, and he pulled the trigger in a big way in 2003.
      Frost bought 880,000 shares of the generic drug maker, making him one of the biggest insider buyers among CEOs. His bet paid off -- the company's shares (IVX:IVX
      News , chart , profile , more

      Delayed quote dataAdd to portfolio
      Create alert Insider
      Sponsored by:
      IVX, , ) soared 96.7 percent in 2003.
      Frost was one of only a small number of corporate insiders who put their money where their faith was last year -- despite the bull market's return. Corporate insiders bought $1.1 billion of stock -- the lowest annual level 1995, according to Thomson Financial data.

10.75-0.09(-0.83%)Apr 29 4:02 PMEDT